Ronald G. Gelbman, Director at HAEMONETICS CORP (HAE), bought 4,442 shares at $45.01 ($200K) on 2006-08-02, disclosed to the SEC on 2006-08-03.
Open-market purchase of $200k HAE by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.98 | 1,500 | $67K | 33.8% |
| 2 | $44.99 | 100 | $4K | 2.3% |
| 3 | $45.00 | 2,000 | $90K | 45.0% |
| 4 | $45.01 | 842 | $38K | 19.0% |
| Total | $44.99 avg | 4,442 | $200K | 100% |
| Filing → |
| HAE | SELL | 2019-02-19 | $1.4M | — | Filing → |
| HAE | SELL | 2018-12-18 | $892K | — | Filing → |
| HAE | SELL | 2017-11-17 | $331K | — | Filing → |